Daratumumab and Carfilzomib Combined Provide Major PFS Benefit in R/R Multiple Myeloma

ORLANDO, Fla.—When added to a regimen of carfilzomib and dexamethasone for patients with relapsed or ...

JANUARY 26, 2020